First Approved Treatment using RNAi – Alnylam Pharmaceuticals’ and BIO Chair John Maraganore
lifestyle December 2nd. 2018, 7:13pmBIO Chair and CEO of Alnylam Pharmaceuticals joins the BIO Buzz Center to discuss an entirely new class of medicines derived from Noble Prize winning discovery of advances in RNAi and his work as BIO Chair.
Email This PostCompensation Disclosure
-
This site receives compensation for referred sales of some or all mentioned products.